Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeting synovitis in knee osteoarthritis
ISRCTN07329370Phase 4Completed
- Sponsor
- Salford Royal NHS Foundation Trust
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of methylprednisolone in knee osteoarthritis (OA) and synovitis, sponsored by Salford Royal NHS Foundation Trust. Primary endpoint: Change in knee pain from baseline to 1 week. Started May 2010; status: completed.
02
Drugs
methylprednisolone
03
Conditions
knee osteoarthritis (OA)synovitis
Beyond the preview
Go deeper on ISRCTN07329370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN07329370.